Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Universitair Ziekenhuis Brussel | OTHER |
Not provided
Not provided
Not provided
Not provided
This prospective comparative study evaluates pain experience in adult patients undergoing laceration repair in the emergency department using either topical lidocaine-adrenaline-tetracaine (LAT) gel or lidocaine infiltration as local anaesthesia. Lidocaine infiltration is the standard anaesthetic technique for wound repair but can cause significant pain during injection. LAT gel is a needle-free topical anaesthetic that is widely used in paediatric patients but has been less studied in adults.
Adult patients presenting with simple lacerations requiring suturing are allocated to receive either LAT gel or lidocaine infiltration according to the clinical judgement of the treating physician. Pain is measured using a visual analogue scale (VAS) during anaesthetic administration, during testing of anaesthetic effectiveness, and during suturing. Additional variables include wound characteristics, patient characteristics, and the need for additional anaesthesia. The study aims to evaluate whether LAT gel provides comparable pain control while reducing pain during anaesthetic administration.
Pain management is an important component of wound treatment in the emergency department. Local anaesthesia is routinely required for laceration repair, most commonly using infiltrative anaesthesia with lidocaine. Although effective, lidocaine infiltration can cause significant discomfort due to the injection itself and may increase patient anxiety. In addition, infiltration can sometimes distort tissue and potentially complicate the suturing procedure. Alternative approaches that reduce pain during anaesthetic administration may therefore improve patient comfort during wound management.
Topical anaesthesia using lidocaine-adrenaline-tetracaine (LAT) gel represents a needle-free alternative to infiltrative anaesthesia. LAT gel is commonly used in paediatric patients and has demonstrated effectiveness in reducing pain during laceration repair. However, evidence regarding its use in adult patients remains limited. Evaluating the effectiveness of LAT gel in adults may help determine whether it can be used more broadly as an alternative to injection-based anaesthesia in the emergency department.
This prospective comparative study includes adult patients presenting to the emergency department of Universitair Ziekenhuis Brussel with simple lacerations requiring suturing. Patients receive either LAT gel or lidocaine infiltration as local anaesthesia according to the clinical judgement of the attending physician. Pain experience is measured using a visual analogue scale (VAS) during anaesthetic administration, during testing of anaesthetic adequacy, and during suturing. Additional variables recorded include patient characteristics, wound characteristics, suturing characteristics, the need for additional anaesthesia, and procedure-related complications. The aim of the study is to compare pain experience between both anaesthetic techniques and to assess whether LAT gel may represent a suitable alternative for selected adult lacerations.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LAT Gel | Experimental | Patients receive topical lidocaine-adrenaline-tetracaine (LAT) gel applied directly into the wound prior to suturing. |
|
| Lidocaine Infiltration | Active Comparator | Patients receive infiltrative local anaesthesia prior to suturing. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lidocaine-Adrenaline-Tetracaine (LAT) Gel | Drug | LAT gel (lidocaine 4%, adrenaline 0.1%, tetracaine 0.5%) is applied directly into the wound at a dose of approximately 0.5 mL per centimetre of wound length and covered with an occlusive dressing for 30 minutes prior to suturing. |
| Measure | Description | Time Frame |
|---|---|---|
| Pain during suturing | Pain experienced during wound suturing measured using a 100 mm visual analogue scale (VAS). | During suturing procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Pain during anaesthetic administration | Pain experienced during administration of the anaesthetic (LAT gel application or lidocaine infiltration) measured using a visual analogue scale (VAS). | At time of anaesthetic administration |
| Pain during testing of anaesthetic effectiveness |
| Measure | Description | Time Frame |
|---|---|---|
| Need for additional anaesthesia | Number of patients requiring additional lidocaine infiltration due to insufficient anaesthetic effect. | During wound preparation prior to suturing |
| Wound characteristics |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Emergency Medicine, Universitair Ziekenhuis Brussel, and Research Group on Emergency and Disaster Medicine | Jette | Brussels Capital | 1090 | Belgium |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 9492129 | Background | Adler AJ, Dubinisky I, Eisen J. Does the use of topical lidocaine, epinephrine, and tetracaine solution provide sufficient anesthesia for laceration repair? Acad Emerg Med. 1998 Feb;5(2):108-12. doi: 10.1111/j.1553-2712.1998.tb02593.x. | |
| 26214220 | Background | Vandamme E, Lemoyne S, van der Gucht A, de Cock P, van de Voorde P. LAT gel for laceration repair in the emergency department: not only for children? Eur J Emerg Med. 2017 Feb;24(1):55-59. doi: 10.1097/MEJ.0000000000000298. |
Not provided
Not provided
Individual participant data that underlie the results reported in this study, after de-identification, may be shared upon reasonable request. Shared data may include demographic characteristics, wound characteristics, treatment allocation, and pain scores measured using the visual analogue scale (VAS).
Data will be available beginning 6 months following publication of the study results and will remain available for up to 5 years after publication.
Data will be available to researchers who provide a methodologically sound proposal for secondary analyses. Proposals should be directed to the corresponding author. Access will be granted after review and approval by the study investigators and the institutional review board when required. Data will be shared in a de-identified format in accordance with institutional and data protection regulations.
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 27, 2020 |
Not provided
Prospective comparative study conducted in the emergency department of Universitair Ziekenhuis Brussel. Adult patients with simple lacerations requiring suturing receive either topical lidocaine-adrenaline-tetracaine (LAT) gel or lidocaine infiltration based on the clinical judgement of the attending physician.
Not provided
Not provided
Not provided
Not provided
| Lidocaine infiltration | Drug | Subcutaneous infiltration of lidocaine 1% is administered locally around the wound approximately 5 minutes prior to suturing. |
|
Pain experienced during testing of anaesthetic adequacy using a needle prick, measured using a visual analogue scale (VAS). |
| After waiting period for anaesthesia (30 minutes LAT gel / 5 minutes lidocaine) |
Description of wound location and wound length.
| At time of emergency department presentation |
| 9291744 | Background | Ernst AA, Marvez-Valls E, Nick TG, Mills T, Minvielle L, Houry D. Topical lidocaine adrenaline tetracaine (LAT gel) versus injectable buffered lidocaine for local anesthesia in laceration repair. West J Med. 1997 Aug;167(2):79-81. |
| Mar 14, 2026 |
| Prot_SAP_000.pdf |
| ICF | No | No | Yes | Informed Consent Form | Feb 28, 2020 | Mar 13, 2026 | ICF_001.pdf |
| ID | Term |
|---|---|
| D022125 | Lacerations |
| D000377 | Agnosia |
| D004630 | Emergencies |
| D014947 | Wounds and Injuries |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D005782 | Gels |
| ID | Term |
|---|---|
| D003102 | Colloids |
| D045424 | Complex Mixtures |
| D004304 | Dosage Forms |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided